Forest Baskett Insider Profile

11 Followers
Forest Baskett

Forest Baskett
Tesaro (TSRO)
Ten Percent Owner

Ranked #97,712 out of 102,052 Corporate Insiders

Profitable Transactions

34%
41 out of 121 Profitable Transactions

Average Return

-10.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2B
16.30%
10.80%
10.62%
9.77%
52.51% Others
A breakdown of Forest Baskett's holdings

Insider Roles

Elastic
(ESTC)
Ten Percent Owner
Robinhood Markets
(HOOD)
Director
Coursera
(COUR)
Ten Percent Owner
Sprout Social
(SPT)
Ten Percent Owner
+30 other positions
Roles that Forest Baskett holds in companies

Most Profitable Insider Trade

Stock:
Achaogen
(AKAOQ)
Rating:Informative Buy
Date:Jun 07, 2016 - Jun 07, 2017
Return:+423.70%
The most profitable trade made by Forest Baskett

Forest Baskett's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
TSRO
Tesaro
Jan 22, 2019
Uninformative Sell
$781.54M
$0.00
Adaptimmune Therapeutics
Jan 28, 2020
Ten Percent Owner
Informative Buy
$4.95M
$188.56M
AVEO Pharma
Oct 21, 2022
Ten Percent Owner
Uninformative Sell
$48.30K
AKAOQ
Achaogen
Dec 19, 2016
Informative Buy
$6.75M
$117.88K
CASC
Cascadian Therapeutics
Mar 13, 2018
Uninformative Sell
$0.00
Regulus
May 09, 2019
Former 10% Owner
Informative Buy
$1.23M
$3.08M
Appian
Feb 15, 2018
Ten Percent Owner
Uninformative Buy
$646.12K
Synlogic
Jan 26, 2018
Ten Percent Owner
Uninformative Buy
$4.00M
$4.12M
Surface Oncology
Apr 23, 2018
Ten Percent Owner
Uninformative Buy
$3.14M
MULE
Mulesoft Inc
May 09, 2018
Uninformative Sell
$0.00
Liquidia Technologies
Aug 01, 2018
Ten Percent Owner
Uninformative Buy
$17.24M
Elastic
Oct 10, 2018
Ten Percent Owner
Uninformative Buy
$348.93M
Genocea Biosciences
May 26, 2022
Ten Percent Owner
Informative Sell
$711.52K
$0.00
Trevi Therapeutics
Apr 13, 2022
Ten Percent Owner
Informative Buy
$5.00M
$24.49M
Mirum Pharmaceuticals
Jul 24, 2019
Ten Percent Owner
Uninformative Buy
$98.88M
Mersana Therapeutics
Sep 16, 2020
Ten Percent Owner
Uninformative Buy
$39.17M
Cloudflare
Nov 13, 2020
Ten Percent Owner
Uninformative Buy
$177.36M
AKOUOS
Dec 02, 2022
Ten Percent Owner
Uninformative Sell
$0.00
Nkarta
Jul 16, 2020
Ten Percent Owner
Uninformative Buy
$14.92M
Inozyme Pharma
Jul 28, 2020
Ten Percent Owner
Uninformative Buy
$4.27M
Metacrine
Dec 27, 2021
Ten Percent Owner
Informative Sell
$493.91K
$1.24M
Eargo
May 26, 2021
Ten Percent Owner
Uninformative Buy
$48.65M
Sprout Social
Nov 17, 2020
Ten Percent Owner
Uninformative Buy
$209.30M
Coursera
Aug 13, 2021
Ten Percent Owner
Uninformative Sell
$227.46M
Monte Rosa Therapeutics
Jun 30, 2021
Ten Percent Owner
Uninformative Buy
$53.69M
Bright Health Group
Jun 30, 2021
Ten Percent Owner
Uninformative Buy
$158.00M
Robinhood Markets
May 04, 2022
Director
Uninformative Sell
$231.20M
IonQ
Nov 18, 2022
Ten Percent Owner
Uninformative Sell
$65.81M
Arcellx Inc
Dec 22, 2022
Ten Percent Owner
Uninformative Sell
$154.89M
Arca Biopharma
Feb 27, 2018
Ten Percent Owner
Informative Sell
$730.10K
$0.00
Ardelyx
Dec 27, 2021
Ten Percent Owner
Informative Sell
$3.63M
$34.41M
TRACON Pharmaceuticals
Mar 27, 2018
Ten Percent Owner
Informative Buy
$1.91M
$5.79M
Supernus Pharmaceuticals
Nov 12, 2015
Ten Percent Owner
Uninformative Buy
$8.73M
DATA
Tableau
Dec 03, 2015
Uninformative Sell
$3.93M
Box
Jan 22, 2015
Ten Percent Owner
Informative Buy
$5.13M
HPTX
Hyperion Therapeutics
May 11, 2015
Uninformative Sell
$109.67M
~DERM
Dermira
Oct 08, 2014
Uninformative Buy
$65.68M
LOXO
Loxo Oncology
Aug 06, 2014
Uninformative Buy
$419.91M
~HIVE
Aerohive Networks
Apr 03, 2014
Uninformative Buy
$20.75M
CRCM
Care
Nov 08, 2017
Uninformative Buy
$33.88M
MM
Millennial Media
Oct 30, 2012
Informative Sell
$21.47M
$14.34M
EPZM
Epizyme
Jan 12, 2016
Informative Buy
$10.00M
$9.20M
ROKA
Sorrento Tech Inc
Jul 22, 2014
Uninformative Buy
$2.09M
Viracta Therapeutics
Aug 29, 2014
Ten Percent Owner
Informative Sell
$2.13M
$9.83M
Workday
Apr 11, 2013
Ten Percent Owner
Uninformative Buy
$1.81M
Clovis Oncology
Jun 05, 2013
Ten Percent Owner
Uninformative Buy
$260.71
Groupon
Sep 17, 2013
Ten Percent Owner
Uninformative Buy
$363.09K
INWK
InnerWorkings
Mar 30, 2012
Uninformative Buy
$44.85K
XOOM
Xoom Corp
Oct 31, 2013
Uninformative Buy
ECHO
Echo Global Logistics
Mar 01, 2012
Uninformative Buy
$9.41K
ADNC
Audience Inc
Dec 04, 2013
Informative Sell
$8.80K
FIO
Fusion-IO
Jun 07, 2011
Informative Buy
OMTH
Omthera
ECOM
ChannelAdvisor
$0.00
List of latest transactions for each holding click on a transaction to see Forest Baskett's performance on stock

Forest Baskett insider profile FAQ

What is the percentage of profitable transactions made by Forest Baskett?
The percentage of profitable transactions made by Forest Baskett is 34%.
    What is the average return per transaction made by Forest Baskett?
    The average return per transaction made by Forest Baskett is -10.20%.
      What stocks does Forest Baskett hold?
      Forest Baskett holds: TSRO, ADAP, AVEO, AKAOQ, CASC, RGLS, APPN, SYBX, SURF, MULE, LQDA, ESTC, GNCAQ, TRVI, MIRM, MRSN, NET, AKUS, NKTX, INZY, MTCR, EAR, SPT, COUR, GLUE, BHG, HOOD, IONQ, ACLX, ABIO, ARDX, TCON, SUPN, DATA, BOX, HPTX, ~DERM, LOXO, ~HIVE, CRCM, MM, EPZM, ROKA, VIRX, WDAY, CLVSQ, GRPN, INWK, XOOM, ECHO, ADNC, FIO, OMTH, ECOM stocks.
        What was Forest Baskett’s latest transaction?
        Forest Baskett latest transaction was an Uninformative Sell of ―.
          What was Forest Baskett's most profitable transaction?
          Forest Baskett’s most profitable transaction was an Informative Buy of AKAOQ stock on June 7, 2016. The return on the trade was 423.70%.
            What is Forest Baskett's role in Tesaro?
            Forest Baskett's role in Tesaro is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.